Financing ·
On July 20, 2026, Omeros Corporation completed the repurchase of approximately $14.5 million in aggregate principal…
OMEROmeros Corp
On July 20, 2026, Omeros Corporation completed the repurchase of approximately $14.5 million in aggregate principal amount of its 9.50% Convertible Senior Notes due 2029 for a total purchase price of approximately $29.0 million, including accrued interest. This follows a previous repurchase of $16.0 million in principal, bringing the total repurchased and retired amount to $30.5 million. Approximately $40.3 million in principal amount of the Notes remains outstanding. The company is a biopharmaceutical company that develops therapeutic drugs.